We previously showed that beta-blockers reduced PKA-phosphorylation of RyR2 in human and canine models of heart failure and in CPVT hiPSC-CMs [11, 45, 46]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.